Table 4.
Mid- and long-term prognosis and follow-up results.
| Overall | Propensity score matched | |||||
|---|---|---|---|---|---|---|
| TAR with FET (n = 311) | Hybrid surgery (n = 23) | P-value | TAR with FET (n = 37) | Hybrid surgery (n = 20) | P-value | |
| Renal insufficiency (%) | 10 (3.2%) | 1 (4.3%) | 0.549 | 0 (0.0%) | 1 (5.0%) | 0.351 |
| Liver insufficiency (%) | 3 (1.0%) | 1 (4.3%) | 0.249 | 1 (2.7%) | 1 (5.0%) | 1.000 |
| Neurological complications (%) | 53 (17.0%) | 12 (52.2%) | <0.001 | 3 (8.1%) | 9 (45.0%) | 0.002 |
| Dizziness (%) | 28 (9.0%) | 8 (34.8%) | 0.001 | 3 (8.1%) | 7 (35.0%) | 0.024 |
| Paraplegia (%) | 8 (2.6%) | 1 (4.3%) | 0.478 | 0 (0.0%) | 1 (5.0%) | 0.351 |
| Unable to walk (%) | 9 (2.9%) | 4 (17.4%) | 0.008 | 0 (0.0%) | 2 (10.0%) | 0.119 |
| New-onset neurological complication (%) | 49 (15.8%) | 8 (34.8%) | 0.038 | 3 (8.1%) | 6 (30.0%) | 0.054 |
| Dizziness (%) | 28 (9.0%) | 7 (30.4%) | 0.005 | 3 (8.1%) | 6 (30.0%) | 0.054 |
| Paraplegia (%) | 5 (1.6%) | 0 (0.0%) | 1.000 | 0 (0.0%) | 0 (0.0%) | - |
| Unable to walk (%) | 4 (1.3%) | 1 (4.3%) | 0.302 | 0 (0.0%) | 0 (0.0%) | - |
| Hoarseness (%) | 44 (14.1%) | 8 (34.8%) | 0.015 | 7 (18.9%) | 5 (25.0%) | 0.736 |
| Limb ischemia (%) | 22 (7.1%) | 1 (4.3%) | 1.000 | 2 (5.4%) | 1 (5.0%) | 1.000 |
| Recurrence of cardiovascular disease (%) | 0 (0.0%) | 1 (4.3%) | 0.070 | 0 (0.0%) | 1 (5.0%) | 0.357 |
| Re-hospitalization (%) | 5 (1.6%) | 4 (17.4%) | 0.002 | 1 (2.7%) | 3 (15.0%) | 0.119 |
| Reoperation (%) | 5 (1.6%) | 0 (0.0%) | 1.000 | 1 (2.7%) | 0 (0.0%) | 1.000 |
The categorical variables in the table are presented by the number of cases (with percentage).